SCHEMBL29080709

SCHEMBL29080709

CC(C)(C)[Si](C)(C)OCCN1CCc2ccccc2C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
MAPT P10636 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
TAAR1 Q96RJ0 1/20 0.50
TDP1 Q9NUW8 2/20 0.49
LMNA P02545 1/20 0.49
ALDH1A1 P00352 2/20 0.49
POLB P06746 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
HTR5A P47898 1/20 0.47
HRH3 Q9Y5N1 1/20 0.47
HTR1A P08908 1/20 0.46
DRD2 P14416 1/20 0.46
HTR2A P28223 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30561530 1.00 KDM4E (0.50) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL22527601 0.92 TDP1 (0.56) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL30541933 0.92 TDP1 (0.56) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL25366880 0.90 CYP1A2 (0.42) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL30528601 0.90 CYP1A2 (0.42) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL30561518 0.83 NR1H2 (0.39) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL20704242 0.83 NR1H2 (0.39) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL6729175 0.83 NR1H2 (0.44) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL30561513 0.83 NR1H2 (0.44) KDM4EMEN1KMT2AMAPTCYP1A2
SCHEMBL7800083 0.82 HRH3 (0.41) KDM4EMEN1KMT2AMAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111094253-B 1, 2-dihydro-3H-pyrazolo [3,4-d ] pyrimidin-3-one analogs 里科瑞尔姆IP控股有限责任公司 2023-08-29 CN disclosed